Akums Financial Statements From 2010 to 2024

AKUMS Stock   609.65  29.00  4.99%   
Akums Drugs financial statements provide useful quarterly and yearly information to potential Akums Drugs and investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Akums Drugs financial statements helps investors assess Akums Drugs' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Akums Drugs' valuation are summarized below:
Profit Margin
0.0578
Market Capitalization
130.9 B
Enterprise Value Revenue
3.3389
Revenue
42.3 B
Earnings Share
0.08
Akums Drugs and does not presently have any fundamental signals for analysis.
Check Akums Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akums Drugs' main balance sheet or income statement drivers, such as , as well as many indicators such as . Akums financial statements analysis is a perfect complement when working with Akums Drugs Valuation or Volatility modules.
  
This module can also supplement various Akums Drugs Technical models . Check out the analysis of Akums Drugs Correlation against competitors.

Akums Drugs and Company Shares Owned By Insiders Analysis

Akums Drugs' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Akums Drugs Shares Owned By Insiders

    
  82.61 %  
Most of Akums Drugs' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akums Drugs and is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 82% of Akums Drugs and are shares owned by insiders. This is much higher than that of the Healthcare sector and notably higher than that of the Drug Manufacturers - Specialty & Generic industry. The shares owned by insiders for all India stocks is notably lower than that of the firm.

Akums Drugs Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Akums Drugs's current stock value. Our valuation model uses many indicators to compare Akums Drugs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akums Drugs competition to find correlations between indicators driving Akums Drugs's intrinsic value. More Info.
Akums Drugs and is rated below average in profit margin category among its peers. It also is rated below average in operating margin category among its peers reporting about  1.53  of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Akums Drugs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Akums Drugs' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Akums Drugs Financial Statements

Akums Drugs investors utilize fundamental indicators, such as revenue or net income, to predict how Akums Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Akums Drugs is entity of India. It is traded as Stock on NSE exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Akums Stock

Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.